Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Babylon, Shikun & Binui, Paz Oil, Teva: Israel Equity Preview

Don't Miss Out —
Follow us on:

Dec. 26 (Bloomberg) -- The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the close unless otherwise stated.

The TA-25 Index dropped the most this month, declining 0.6 percent to 1,305.45 at the close in Tel Aviv.

Babylon Ltd. (BBYL IT): The translation software developer renewed a cooperation agreement with Google Inc. for two years. Babylon rose 1.3 percent to 4.863 shekels.

Paz Oil Co. (PZOL IT): The maker of oil-based products received notification of a class-action lawsuit against the company accusing it of selling inferior products. Paz gained 0.7 percent to 630 shekels.

Shikun & Binui Ltd. (SKBN IT): The construction company’s rating was raised to ilA from ilA- with the outlook changed to "stable" from "negative" at Standard & Poor’s Maalot. Shikun & Binui fell 0.6 percent to 9.8 shekels.

Teva Pharmaceutical Industries Ltd. (TEVA IT): The world’s largest maker of generic drugs failed to win U.S. approval for a new formulation of its top-selling multiple sclerosis medicine Copaxone and said regulators may require a new study to prove that it works. Teva declined 0.8 percent to 182.40.

To contact the reporter on this story: Calev Ben-David in Jerusalem at cbendavid@bloomberg.net

To contact the editor responsible for this story: Peter Hirschberg in Jerusalem at phirschberg@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.